Theresia Mikolasch - Concepedia

Author

Theresia Mikolasch

Also Known As

T Mikolasch, T. Mikolasch, T.A. Mikolasch, Theresia A Mikolasch, Theresia A. Mikolasch, Theresia Auguste Mikolasch, Theresia Mikolasch

Publications

Citations

H-Index

Concepts

All Affiliations

University College London University of Bristol University of Nottingham University of Oxford Nottingham University Hospitals NHS Trust

About

Theresia Mikolasch is an author at University College London specializing in medicine, pulmonary medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	505
2	Immunology	2	2	123
3	Molecular Medicine	1	1	98
4	Pathology	1	1	98
5	Pulmonary Disease	1	1	25

Theresia Mikolasch

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Update in diagnosis and management of interstitial lung disease Theresia Mikolasch, Helen Garthwaite, Joanna C. Porter Clinical Medicine Translational MedicineMolecular Diagnostic TechniquesPrognostic BiomarkersInflammatory Lung DiseaseDiagnostic Process	2017	98
Identification of a Novel HIF-1α-αMβ2 Integrin-NET Axis in Fibrotic Interstitial Lung Disease Akif A. Khawaja, Deborah L. W. Chong, Jagdeep Sahota, Frontiers in Immunology	2020	36
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis Theresia Mikolasch, Peter M. George, Jagdeep Sahota, EClinicalMedicine InflammationClinical Risk StratifierIndependent PredictorClinical EpidemiologyImmunology	2022	25
Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis Deborah L. W. Chong, Theresia Mikolasch, Jagdeep Sahota, American Journal of Physiology-Lung Cellular and Molecular Physiology	2023	12

Page 1